“Our country will flourish and be respected again all over the world. We will be the envy of every nation, and we will not allow ourselves to be taken advantage of any longer. We’re going to reclaim ...
Structure Therapeutics Inc. is a clinical-stage biotech focused on oral GLP-1 drugs for obesity, targeting a rapidly growing sector in pharma market. GPCR's valuation appears attractive given a $1B ...
Robin Wright is the latest Hollywood celebrity to say she’s happily living in the U.K. “America is a (expletive) show,” she told The Sunday Times in an interview published Aug. 30. She did not raise ...
When Alham Carter, Tevin McDaniel and Aurelius Francisco launched the Foundation for Liberating Minds in 2017, it was, at first, a dream that had just manifested out of their heads and into the real ...
1 Institute of Tourism Research, Huainan Normal University, Huainan, China 2 Key Laboratory of Digital-Intelligent Disease Surveillance and Health Governance, North Sichuan Medical College, Nanchong, ...
SAN FRANCISCO, June 20, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for ...
Structure Therapeutics to present promising data on ACCG-2671 for obesity and GLP-1 receptor agonists for Parkinson's at ADA 2025. Structure Therapeutics announced two late-breaking poster ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback